Get started
Author

Emily English

Observed name: Emily P. English
ORCID: 0009-0000-1621-4669
Observed ORCID: 0009-0000-1621-4669
OpenAlex ID: A5033169160
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
2023 · Volkan Granit, Michael Benatar, et al. · The Lancet Neurology · 313
PDF
Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting
2022 · Millie D Long, Anita Afzali, et al. · Inflammatory Bowel Diseases · 30
PDF
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial
2026 · Renee R. Fedak, Rachel N. Ruggerie, et al. · Nature Medicine · 26
PDF
Efficacy and Safety of Liraglutide in Patients With an Ileal Pouch-Anal Anastomosis and Chronic High Bowel Frequency: A Placebo-Controlled, Crossover, Proof-of-Concept Study
2024 · Hans Herfarth, Millie D. Long, et al. · The American Journal of Gastroenterology · 11
Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry
2023 · Hans H. Herfarth, Anita Afzali, et al. · Clinical and Translational Gastroenterology · 4
S0668 Time to Improvement in Patient-Reported Outcomes With Tofactinib in Ulcerative Colitis: Initial Results From a Real World Prospective Multicenter Study (TOUR)
2020 · Millie Long, Maisa Abdalla, et al. · The American Journal of Gastroenterology · 1
Su1752 EFFICACY AND SAFETY OF LIRAGLUTIDE IN PATIENTS WITH PATIENTS WITH AN ILEAL -POUCH-ANAL ANASTOMOSIS (IPAA) AND CHRONIC HIGH BOWEL FREQUENCY – PLACEBO-CONTROLLED, CROSSOVER, PROOF OF CONCEPT STUDY
2024 · Hans H. Herfarth, Millie D. Long, et al. · Gastroenterology
Tu1799 ASSOCIATION OF EARLY CLINICAL EFFICACY FACTORS WITH 1-YEAR RESPONSE AND REMISSION TO TOFACITINIB IN MODERATE TO SEVERE ULCERATIVE COLITIS IN A REAL WORLD PROSPECTIVE MULTICENTER STUDY (TOUR)
2023 · Millie D. Long, Anita Afzali, et al. · Gastroenterology
PDF
S931 Initial 8-week Therapy with Tofacitinib in Moderate-to-Severe Ulcerative Colitis in a Real World Prospective Multicenter Study (TOUR)
2021 · Millie D. Long, Anita Afzali, et al. · The American Journal of Gastroenterology
Assessing the validity of an IRB approved REDCap web based clinical trials recruitment registry
2018 · Deanna K. Hamilton, Edwin H. Kim, et al. · Journal of Allergy and Clinical Immunology
PDF
Works count: 10
Citation count: 385
H-index: 4
I10-index: 4
Year
Topic
Type